期刊文献+

肌钙蛋白Ⅰ测定在急性亚硝酸盐中毒监测中的临床意义 被引量:1

Clinical significance of serum cardiac troponin Ⅰ in acute nitrite poisoning
下载PDF
导出
摘要 目的观察急性亚硝酸盐中毒患者肌钙蛋白Ⅰ的变化,分析其与疾病程度和预后的关系。方法132例急性亚硝酸盐中毒患者,均于发病后3 h内进入急诊抢救室治疗。于入院后3和24 h测定肌钙蛋白Ⅰ。将患者分为肌钙蛋白Ⅰ正常组(A组)和肌钙蛋白Ⅰ升高组(B组),比较两组患者急性生理与慢性健康状况评分(APACHE)Ⅱ、脏器衰竭率和病死率。结果B组APACHEⅡ评分为(20±7)分,明显高于A组的(11±3)分(P<0.05)。B组脏器衰竭率和病死率分别为20.0%和12.9%,均明显高于A组的0%和0%(P值均<0.01)。结论急性亚硝酸盐中毒患者中肌钙蛋白Ⅰ升高者的APACHEⅡ评分高、预后差。肌钙蛋白Ⅰ测定可作为急性亚硝酸盐中毒预后监测的一项可靠指标。 Objective To detect the changes of the serum cardiac troponin Ⅰ (cTnI) in acute nitrite poisoning and analyze the relationship between serum cTnI level and the degree of severity together with the prognosis. Methods The serum cTnI level was measured in 132 cases of acute nitrite poisoning patients on the 3rd and 24th hour after hospitalization. The patients were divided into group A with normal serum cTnI and group B with high serum cTnI levels. Comparing the acute physiologic and chronic health evaluations(APACHE) Ⅱ, the organic failure rates and mortality rates between the two groups. Results The organic failure rate and mortality rate were significantly higher in group B than those in group A. The APACHE Ⅱ scoring was significantly higher in group A than that of group B. Conclusion There is a positive correlationships between the serum cTnI level and APACHE Ⅱ, of which the serum cTnI level can be taken as a reliable monitoring prognostic factor in acute nitrite intoxication patients. (Shanghai Med J, 2006, 29:653 655)
作者 巴建明
出处 《上海医学》 CAS CSCD 北大核心 2006年第9期653-655,共3页 Shanghai Medical Journal
关键词 肌钙蛋白Ⅰ 急性亚硝酸盐中毒 急性生理与慢性健康状况评分Ⅱ Cardiac troponin Ⅰ Acute nitrite poisoning Acute physiology and chronic health evaluation Ⅱ
  • 相关文献

参考文献6

二级参考文献53

  • 1傅荫宇.实用临床科研方法学,第1版[M].北京:中国协和医科大学北京医科大学联合出版社,1990.55-62.
  • 2[1]Wu A H B. Biochemical markers of cardiac damage: from traditional enzymes to cardiac-specific proteins[J]. Scand J Clin Lab Invest,1999,59(Suppl 230): 74-82.
  • 3[2]Panteghni M, Apple F S, Christenson R H, et al. Proposal from IFCC committee on Standadization of Markers of Cardiac Damage (C-SMCD): recommendation on use of biochemical markers of cardiac damage in acute coronary syndromes [J]. Scand J Clin Lab Invest, 1999,59(Suppl 230): 103-112.
  • 4[3]Wu A H,Apple F S ,Gibler W B, et al. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery disease[J]. Clin Chem,1999,45: 1104-1121.
  • 5[4]Alpert J S, Thygesen K, Antman E, et al. Myocardial infarction redefined:a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction[J]. J Am Coll Cardiol, 2000,36: 959-969.
  • 6[5]Giri S,Waters D D,Wu A H B. Pathophysiology of acute coronary syndromes In: Card iac markers. Ed. Wu A H B. New Jersey:Humana Press Inc, 1998.21-44.
  • 7[6]Winter R J, Fischer J, Bholasingh R, et al. C-reactive protein and cardiac troponin T in risk stratification:differences in optimal timing of tests early after the onset of chest pain[J]. Clin Chem,2000,46:1597-1603.
  • 8[7]Koenig W, Sund M, Frohlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary, heart disease in initial healthy middle-aged men: results from the MONICA Augsburg Cohort Study, 1984 to 1992 [J]. Circulation, 1999, 99:237-242.
  • 9[8]Zimmerman J, Fromm R, Meyer D, et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction [J].Circulation, 1999,99: 1671-1677.
  • 10[9]Roberts W T, Sedrick R, Moulton L, et al. Evaluation of four automated high-sensitivity C-reactive protein methxts: implications for clinical and epidemiological applications[J]. Clin Chem, 2000,46:461-468.

共引文献669

同被引文献3

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部